Rapid decline of viral DNA in hepatitis C patients treated with VX-950:A phase 1b,placebo-controlled,randomized study .Interim results from HCV SPRINT-1:RVR/EVR from phase 2 study of boceprevir plus peginterferon alfa-2b/ribavirin in treatment na ? ve sub ......